About the journal
Therapeutics and Clinical Risk Management is an open-access journal published by Dove Medical Press in United Kingdom, publishing in english. It is listed in DOAJ and PUBMED according to the sources read. Declared publication charge: 3,940 USD. Declared review time at DOAJ: 16 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Dove Medical Press
- ISSN
- 1176-6336 · 1178-203X
- Country
- United Kingdom
- Languages
- english
- Access
- Open access
- Declared publication charge
- 3,940 USD
- Articles in DOAJ
- 2308
- Declared review time
- 16 weeks
- Declared peer-review model
- other
Index listings
- DOAJ · 2009-06-05
- PUBMED · 2010-02-02
- Indexing
- DOAJ · PUBMED
- APC
- 3,940 USD
- Declared review time (DOAJ)
- 16 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
2308
Most recent article
2 months ago
Average review time (journal-declared via DOAJ)
16weeks
Works in OpenAlex
2513
Last recorded publication year
2026
h-index
90
i10-index
1408
From OpenAlex open data (CC0).
Editorial & policy13
- Last DOAJ review date
- 2026-04-27
- Added to DOAJ
- 2009-06-05
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Declared digital preservation
- CLOCKSSPMC
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSS
- Editorial board
- Official page ↗
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 87%
- ORCID iDs in current deposits
- 66%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
- APC waiver policy
- View policy
- Peer-review policy
- View policy
Identity & continuity2
- Source type
- journal
- NLM unique ID (PubMed)
- 101253281
Classification2
Subjects (DOAJ)
LCC codes
Subject areas
- Anesthesia and Pain Management
- Asthma and respiratory diseases
- Asthma and respiratory diseases
- Anesthesia and Sedative Agents
- Asthma and respiratory diseases
- Pharmaceutical Practices and Patient Outcomes
- Bone health and osteoporosis research
- Pharmacovigilance and Adverse Drug Reactions
Show all subjects (75)
- Acute Myocardial Infarction Research
- Anesthesia and Sedative Agents
- Anesthesia and Sedative Agents
- Pharmacy and Medical Practices
- Anesthesia and Pain Management
- Anesthesia and Pain Management
- Sepsis Diagnosis and Treatment
- Bone health and treatments
- Bone health and osteoporosis research
- Bone health and osteoporosis research
- Enhanced Recovery After Surgery
- Sepsis Diagnosis and Treatment
- Enhanced Recovery After Surgery
- Sepsis Diagnosis and Treatment
- Inflammatory Biomarkers in Disease Prognosis
- Rheumatoid Arthritis Research and Therapies
- Venous Thromboembolism Diagnosis and Management
- Bone health and treatments
- Venous Thromboembolism Diagnosis and Management
- Pharmaceutical Practices and Patient Outcomes
- Bone health and treatments
- Diabetes Treatment and Management
- Pharmaceutical Practices and Patient Outcomes
- Airway Management and Intubation Techniques
- Dialysis and Renal Disease Management
- Atrial Fibrillation Management and Outcomes
- Airway Management and Intubation Techniques
- Atrial Fibrillation Management and Outcomes
- Cardiac, Anesthesia and Surgical Outcomes
- Pain Management and Opioid Use
- Cardiac, Anesthesia and Surgical Outcomes
- Airway Management and Intubation Techniques
- Enhanced Recovery After Surgery
- Diabetes Treatment and Management
- Diabetes Treatment and Management
- Venous Thromboembolism Diagnosis and Management
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Inflammatory Biomarkers in Disease Prognosis
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Bone fractures and treatments
- Rheumatoid Arthritis Research and Therapies
- Acute Myocardial Infarction Research
- Inflammatory Biomarkers in Disease Prognosis
- Antiplatelet Therapy and Cardiovascular Diseases
- Lipoproteins and Cardiovascular Health
- Heart Failure Treatment and Management
- Acute Myocardial Infarction Research
- Rheumatoid Arthritis Research and Therapies
- Acute Ischemic Stroke Management
- Nausea and vomiting management
- Nausea and vomiting management
- HIV/AIDS drug development and treatment
- HIV/AIDS drug development and treatment
- Respiratory and Cough-Related Research
- Respiratory and Cough-Related Research
- Pharmacological Effects and Toxicity Studies
- Acute Kidney Injury Research
- Antiplatelet Therapy and Cardiovascular Diseases
- Pharmacological Effects and Toxicity Studies
- Antiplatelet Therapy and Cardiovascular Diseases
- Acute Kidney Injury Research
- Heart Failure Treatment and Management
- Heart Failure Treatment and Management
- Nosocomial Infections in ICU
- Lipoproteins and Cardiovascular Health
- Nosocomial Infections in ICU
- Lipoproteins and Cardiovascular Health
Keywords (DOAJ)
- clinical therapeutics
- clinical risk management
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ